Ergebnis der Suchanfrage nach Celle

Orte

Alle 16 Treffer anzeigenweniger anzeigen

Landkreis Celle LK Celle - Wienhausen Nienhagen (Landkreis Celle)Stadt Celle Altencelle Westercelle

Themen

Excellence Award HR Excellence Award HR Excellence Awards

Inhalte

Neueste Relevanteste

Filtern

603 Treffer

12.01.2011 – 10:32
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG Announces Data from Talactoferrin Phase II Trial in Severe Sepsis to be Presented at 40th Critical Care Congress of the Society of Critical Care Medicine
Further inquiry note: Agennix AG Barbara Mueller Manager, Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Senior Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for ...
mehr
09.12.2010 – 16:50
Finanzen
Wacker Chemie AG
EANS-News: WACKER Builds New Polysilicon Production Facility in the USA
- Integrated production site with an annual capacity of 15,000 metric tons in the U.S. State of Tennessee - Some 650 new jobs expected from 1.1 billion investment - Completion scheduled for end of 2013 - CEO Rudolf Staudigl: This large-scale investment is instrumental in strengthening our position as one of the worlds leading suppliers of hyperpure polysilicon ...
mehr
19.11.2010 – 12:16
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG to Present at Two Investor Conferences in November
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: ...
mehr
18.11.2010 – 07:31
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG Reports Financial Results For Third Quarter and First Nine Months of 2010 - Company Also Provides Update on Clinical Development Progress and Changes
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
mehr
05.11.2010 – 10:03
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG /Agennix Awarded Approximately $490,000 Under U.S. Qualifying Therapeutic Discovery Project Grant Program
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
mehr
04.11.2010 – 02:33
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG /dievini Hopp BioTech Holding and Related Persons and Entities Granted Exemption from Mandatory Tender Offer for Agennix AG
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: ...
mehr

04.11.2010 – 02:12
Finanzen
AGENNIX AG i.L.
EANS-Adhoc: AGENNIX AG /dievini Hopp BioTech Holding and Related Persons and Entities Granted Exemption from Mandatory Tender Offer for Agennix AG
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: ...
mehr
29.10.2010 – 08:03
Finanzen
ElringKlinger AG
EANS-Adhoc: Sales at ElringKlinger up 40% year-on-year after first nine months
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications/Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen/Erms Phone: +49 (0)7123 724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt ...
mehr
28.10.2010 – 10:05
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG Schedules Conference Call on November 18, 2010 to Discuss Third Quarter 2010 Financial Results
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Raimund ...
mehr
07.10.2010 – 11:49
Finanzen
PNE WIND AG
EANS-Adhoc: The Stade District Court dismisses entirely the action against PNE WIND AG with an amount in dispute of EUR 54.28 million in connection with the sale of the stake in SSP Technology A/S
Further inquiry note: PNE WIND AG Presse- und Öffentlichkeitsarbeit Rainer Heinsohn Tel: +49(0) 47 21 - 7 18 - 4 53 Fax: +49(0) 47 21 - 7 18 - 3 73 E-mail: info@pnewind.com Investor Relations cometis AG Ulrich Wiehle / Alexandra Edinger Tel: +49(0)611 - 205855-16 Fax: +49(0)611 - 205855-66 E-mail: ...
mehr
05.10.2010 – 17:59
Finanzen
ElringKlinger AG
EANS-News: ElringKlinger AG resolves on capital increase from Authorized Capital
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations/PR Max-Eyth-Straße 2, 72581 Dettingen/Erms Phone: +49 (0)7123-724-640 / 137 Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
mehr
05.10.2010 – 17:56
Finanzen
ElringKlinger AG
EANS-Adhoc: ElringKlinger AG resolves on capital increase
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations/PR Max-Eyth-Straße 2, 72581 Dettingen/Erms Phone: +49 (0)7123-724-640 / 137 Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade ...
mehr

01.10.2010 – 11:15
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG Raises Approximately EUR 76 Million in Net Proceeds in Capital Increase
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free ...
mehr
01.10.2010 – 11:05
Finanzen
AGENNIX AG i.L.
EANS-Adhoc: AGENNIX AG / Agennix AG Raises Approximately EUR 76 Million in Net Proceeds in Capital Increase
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media ...
mehr
15.09.2010 – 01:36
Finanzen
AGENNIX AG i.L.
EANS-Adhoc: AGENNIX AG / Agennix AG Sets Subscription Price at EUR 3.81 per Share for Capital Increase and Subscription Period Planned to Begin on September 17, 2010 -Dievini Hopp BioTech holding Provides Firm Commitment to Invest up to EUR 80 Million
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
mehr
03.09.2010 – 10:01
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG / Agennix AG Announces Data from Talactoferrin Randomized, Double-Blind, Placebo-Controlled Phase II Trial in Severe Sepsis Presented at the Sepsis 2010 International Symposium
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
mehr
05.08.2010 – 08:46
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG /
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: +49 (0)89 210 228 0 raimund.gabriel@mc-services.eu Additional investor contact for Europe: Trout International LLC Lauren Williams, Vice President ...
mehr
05.08.2010 – 08:37
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG /
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: +49 (0) 89 210 228 0 raimund.gabriel@mc-services.eu Additional investor contact for Europe: Trout International LLC Lauren Williams, Vice President ...
mehr

30.07.2010 – 08:04
Finanzen
ElringKlinger AG
EANS-Adhoc: ElringKlinger raises sales by 43% in first half of 2010
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications/Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen/Erms Phone: +49 (0)7123 724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free ...
mehr
29.07.2010 – 10:14
Finanzen
AGENNIX AG i.L.
EANS-News: AGENNIX AG /
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional ...
mehr
23.07.2010 – 16:46
Finanzen
AGENNIX AG i.L.
EANS-Adhoc: AGENNIX AG /
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional investor contact for Europe: Trout ...
mehr
21.05.2010 – 15:15
Finanzen
ElringKlinger AG
EANS-News: ElringKlinger AGM approves dividend increase: solid start to fiscal 2010
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Fon: +49 (0)7123-724-631; +49 (0)170-9246264; Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All ...
mehr
10.05.2010 – 07:56
Finanzen
ElringKlinger AG
EANS-Adhoc: Market recovery and new ramp-ups contribute to 41% growth in ElringKlinger sales during first quarter of 2010
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
mehr
30.03.2010 – 07:50
Finanzen
ElringKlinger AG
EANS-Adhoc: Annual results for 2009: ElringKlinger defies industry crisis with cost streamlining and upturn in sales during second half
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
mehr

10.03.2010 – 12:30
Panorama
BASF SE
BASF Podcast: The Chemical Reporter - What are fungicides?
Ludwigshafen (ots) - Just like animals and human beings, plants can get sick. In many cases, the cause is a fungus. Not a mushroom like you see poking up out of the ground in the woods, but a network of branching, filamentary cells that botanists call 'hyphae'. In entertaining episodes our Chemical Reporter answers questions of our Podcast listeners ...
Ein Audio
mehr
15.02.2010 – 09:16
Finanzen
LPKF Laser & Electronics AG
EANS-News: LPKF Laser & Electronics AG / LPKF expands production capacities for laser systems
Further inquiry note: LPKF Laser & Electronics AG Bettina Schäfer, Investor Relations Tel: (05131) 7095-382 Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade ...
mehr
20.01.2010 – 11:48
Finanzen
init innovation in traffic systems AG
EANS-News: init innovation in traffic systems AG / init improves incident management in local public transportation: No more time loss due to diversions
- Innovation Award for new online diversion module in operations control system - Prompt reaction to current traffic disruptions, real-time information for passengers - On-road test at Bavarian transportation provider DB Stadtverkehr Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 ...
mehr
17.12.2009 – 13:34
Wirtschaft
Boehringer Ingelheim
Boehringer Ingelheim Initiates First Phase III Clinical Trial in Ovarian Cancer
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent[1], ...
mehr
02.11.2009 – 08:05
Finanzen
ElringKlinger AG
EANS-Adhoc: ElringKlinger buoyed by upturn in sales and cost reductions in Q3 2009
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations / Corporate Communications Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
mehr
30.09.2009 – 08:21
Finanzen
Wacker Chemie AG
EANS-News: WACKER Exits from Solar Wafer Business
- SCHOTT Solar acquires WACKER's shares in joint venture - WACKER is expecting from the transaction a non-recurring negative effect on pre-tax profit of about 50 million, financial debt to increase by some 65 million - CEO Staudigl: Focus on polysilicon production provides an excellent base for long-term competitiveness and profitability Further inquiry note: Christof Bachmair Media Relations & Information Tel.: ...
mehr

Vorherige12131415161718192021Nächste